Bioavailability: Why Label Dose and Delivered Dose Differ

The amount printed on a label is the amount in the bottle, not the amount that reaches you.

What determines it

Bioavailability is the proportion of an ingested dose reaching systemic circulation in active form. It is affected by solubility, stability in stomach acid, intestinal permeability, efflux transporters, and first-pass metabolism in the gut wall and liver. For central nervous system purposes there is an additional filter: the blood-brain barrier, which many compounds cross poorly. A compound can be well absorbed systemically and still barely reach the brain.

What changes it

Food is a major variable and direction differs by compound: fat-soluble compounds absorb better with a fat-containing meal, while amino acids compete for transport and absorb better away from protein. Stomach acid matters, so acid-reducing medication changes absorption of some nutrients. Individual variation from microbiome composition and transit time is substantial. Splitting a dose can improve total absorption for compounds with saturable uptake.

Formulation claims

Liposomal delivery, phytosome complexes, nanoemulsions and absorption enhancers such as piperine all appear in marketing. Some have genuine comparative data; many are applied without head-to-head testing. The question worth asking is whether a comparative absorption study exists for that specific product rather than for the technology in general. Liquid formats sometimes claim absorption advantages, which for most compounds affects speed more than total uptake.

Cognicept in context

Nothing on this page is a claim about Cognicept specifically. Cognicept is a dietary supplement providing nutritional support for memory and focus; it is not a treatment for memory loss, dementia, anxiety or cognitive decline. Persistent or worsening memory symptoms warrant medical assessment, because several causes are checkable and correctable. For an honest read on the money, our value for money review states both sides.